No Data
No Data
Barclays Maintains Sotera Health Company(SHC.US) With Buy Rating, Raises Target Price to $15
Express News | Sotera Health Company : Barclays Raises Target Price to $15 From $12
Sotera Health Co (SHC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges
Sotera Health Company | 10-Q: Q1 2025 Earnings Report
Sotera Health Shares Are Trading Higher Following a Q1 Adjusted EPS and Revenue Beat. Also, the Company Issued FY25 Revenue Guidance Above Estimates.
Sotera Health Q1 Adjusted Earnings, Revenue Increase